HOME >> MEDICINE >> NEWS
NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks

nue for up to seven years.

The research structure resulting from this competition will enable NIAID's Division of AIDS to more effectively respond to global research needs, including those of people of color, those who live in poverty, and women, all of whom are increasingly affected by the HIV/AIDS pandemic and continue to be under-represented in clinical research.

"We are pleased to be making this announcement on World AIDS Day," says Dr. Fauci, "as this year's World AIDS Day theme focuses on 'Women, Girls, HIV and AIDS'."

Each network leadership group selected as part of this competition will work with NIAID and other NIH Institutes on a focused research effort. To most effectively coordinate across disciplines, each network can address significant scientific questions in one or more of six priority research areas

  • Developing HIV vaccines
  • Translating research insights into therapeutic products to treat HIV disease
  • Optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions
  • Developing microbicides to prevent HIV acquisition and transmission
  • Preventing mother-to-child transmission of HIV
  • Developing other methods of HIV prevention

    The decision to revamp the clinical research structure emerged following extensive consultations with researchers, clinicians, community, nurses, advocates and people living with and at risk for HIV/AIDS. The new approach is designed to increase the efficiency, accountability and integration of NIAID's HIV/AIDS clinical research networks and enhance their capacity to effectively conduct vital clinical research, especially in resource-limited settings. Specifically, the new clinical research structure will

  • Maximize scientific opportunities by integrating and coordinating HIV/AIDS prevention, vaccine and therapeutic research and maintaining a flexible and responsive approach to emerg
    '"/>


  • Contact: NIAID Press Office
    niaidnews@niaid.nih.gov
    301-402-1663
    NIH/National Institute of Allergy and Infectious Diseases
    1-Dec-2004


    Page: 1 2 3

    Related medicine news :

    1. NIAID initiates trial of experimental avian flu vaccine
    2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
    3. NIAID begins enrolling volunteers for novel HIV vaccine study
    4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
    5. NIAID launches influenza genome sequencing project
    6. NIAID launches program to improve medical tools against emerging infectious diseases
    7. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
    8. NIAID rotavirus vaccine licensed for commercialization
    9. Second NIAID SARS vaccine candidate helps mice fend off SARS
    10. NIAID vaccine protects against SARS virus infection in mice
    11. NIAID Ebola vaccine enters human trial

    Post Your Comments:
    (Date:4/23/2014)... State University researcher is looking to give exercise enthusiasts ... her latest research shows that a cyber buddy can ... Games for Health Journal , is the first to ... better motivator during exercise, a software-generated partner also can ... that isn,t real can still motivate people to give ...
    (Date:4/23/2014)... University researchers have identified an important enzyme pathway that ... too few chromosomes, a condition that has been directly ... associate professor of biochemistry, found that near the end ... enzyme that ensures any breaks in DNA are fully ... genome to daughter cells. This process helps safeguard against ...
    (Date:4/23/2014)... could help doctors predict which patients might suffer potentially ... The program, which assesses brain scans using pattern recognition ... passport control, has been developed by researchers at Imperial ... the Wellcome Trust, which used the software are published ... Stroke affects over 15 million people each year worldwide. ...
    (Date:4/23/2014)... displayed in the popular Swedish children,s TV show ... foods. A new study from the University of ... TV programmes as well as the link between ... status. , Steingerdur Olafsdottir,s doctoral thesis focuses on ... children,s TV show Bolibompa. Healthy foods dominated in ...
    (Date:4/23/2014)... about an increase in adolescents, marijuana use following the ... relief. According to a new study at Rhode Island ... states with and without medical marijuana laws, legalizing the ... The study is published online in advance of print ... , "Any time a state considers legalizing medical marijuana, ...
    Breaking Medicine News(10 mins):Health News:Cyber buddy is better than 'no buddy' 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:Airport security-style technology could help doctors decide on stroke treatment 2Health News:Airport security-style technology could help doctors decide on stroke treatment 3Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2
    (Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
    (Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
    (Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
    Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
    Cached News: